[Differentiated approaches to the treatment of chronic pancreatitis patients with metabolic syndrome].
study and evaluation of clinical efficacy of combined use of Creon and Tricor in chronic pancreatitis (CP) accompanied by metabolic syndrome (MS). We observed 60 patients with CP accompanied by MS, of whom 30 patients received standard therapy complex CPs (comparison group), 30--received Creon (microspheres of pancreatin) and Tricor (fenofibrate) in the combined treatment (observation group). In assessing the effectiveness of therapies used in clinical and advanced laboratory and instrumental studies. In the course of treatment in patients with the observation group occurred faster clinical improvement, improved lipid, carbohydrate and purine exchange and decreased insulin resistance. The combined use of Creon and Tricor is pathogenetically substantiated and clinically effective in the CP accompanied by MS.